cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3

American Journal of Physiology - Renal Physiology

Volumn 290, Issue 6, 2006, Pages

  Beierwaltes, William H ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

cAMP; Furosemide; Milrinone; Nitric oxide; Zaprinast

Indexed keywords

CYCLIC AMP; CYCLIC GMP; FUROSEMIDE; MILRINONE; NITRIC OXIDE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE V; RENIN; THIOBUTABARBITAL; ZAPRINAST;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; HEMODYNAMICS; KIDNEY ARTERY; KIDNEY BLOOD FLOW; KIDNEY METABOLISM; KIDNEY VEIN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN RELEASE;

EID: 33744803170     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00209.2005     Document Type: Article

References (31)

1. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75: 725-748, 1995.
2. Beierwaltes WH. Selective neuronal nitric oxide synthase inhibition blocks furosemide-stimulated renin secretion in vivo. Am J Physiol Renal Fluid Electrolyte Physiol 269: F134-F139, 1995.
3. Beierwaltes WH. Macula densa stimulation of renin is reversed by selective inhibition of neuronal nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 272: R1359-R1364, 1997.
4. Beierwaltes WH and Carretero OA. Nonprostanoid endothelium-derived factors inhibit renin release. Hypertension 19, Suppl II: II68 -II73, 1992.
5. Castrop H, Sweda F, Mizel D, Huang Y, Briggs J, Kurtz A, and Schnermann J. Permissive role of nitric oxide in macula densa control of renin secretion. Am J Physiol Renal Physiol 286: F848-F857, 2004.
6. Chiu YJ, Hu SH, and Reid IA. Inhibition of phosphodiesterase III with Milrinone increases renin secretion in human subjects. J Pharmacol Exp Ther 290: 16-19, 1999.
7. Chiu T and Reid IA. Role of cyclic GMP-inhibitable phosphodiesterase and nitric oxide in the beta adrenoreceptor control of renin secretion. J Pharmacol Exp Ther 278: 793-799, 1996.
8. Churchill PC. Second messengers in renin secretion. Am J Physiol Renal Fluid Electrolyte Physiol 249: F175-F184, 1985.
9. Dousa TP. Cyclic-3′,5′-nucleotide phophodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int 55: 29-62, 1999.
10. Friis UG, Jensen BL, Sethi S, Andreasen D, Hansen PB, and Skott O. Control of renin secretion from rat juxtaglomerular cells by cAMP-specific phosphodiesterases. Circ Res 90: 996-1003, 2002.
11. Harding P, Carretero OA, and Beierwaltes WH. Chronic inhibition of cyclooxygenase-2 blunts low sodium-stimulated renin without changing renal hemodynamics. J Hypertens 18: 1107-1113, 2000.
12. Harding P, Sigmon DH, Alfie ME, Huang PL, Fishman MC, Beierwaltes WH, and Carretero OA. Cyclooxygenase-2 mediates increased renal renin content induced by low sodium diet. Hypertension 29: 297-302, 1997.
13. Harris RC, McKenna JA, Akai Y, Jacobson HR, Dubois RN, and Brayer MD. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 94: 2504-2510, 1994.
14. He XR, Greenberg SG, Briggs JP, and Schnermann JB. Effect of nitric oxide on renin secretion. II. Studies in the perfused juxtaglomerular apparatus. Am J Physiol Renal Fluid Electrolyte Physiol 268: F953-F959, 1995.
15. Henrich WL, McAllister EA, Smith PB, and Campbell WB. Guanosine 3′,5′-cyclic monophosphate as a mediator of inhibition of renin release. Am J Physiol Renal Fluid Electrolyte Physiol 255: F474-F478, 1988.
16. Johnson RA and Freeman RH. Renin release in rats during blockade of nitric oxide synthesis. Am J Physiol Regul Integr Comp Physiol 266: R1723-R1729, 1994.
17. Keeton TK and Campbell WB. The pharmacologic alteration of renin release. Pharmacol Rev 32: 81-277, 1980.
18. Krämer GK, Ritthaler T, Ackermann M, Holmer S, Schricker K, Riegger GAJ, and Kurtz A. Endothelium-mediated regulation of renin secretion. Kidney Int 46: 1577-1579, 1994.
19. Kurtz A, Della Bruna R, Pfeilschifter J, Taugner R, and Bauer C. Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process. Proc Natl Acad Sci USA 83: 4769-4773, 1986.
20. Kurtz A, Götz KH, Hamann M, Kieninger M, and Wagner C. Stimulation of renin secretion by NO donors is related to the cAMP pathway. Am J Physiol Renal Physiol 274: F709-F712, 1998.
21. Kurtz A, Götz KH, Hamann M, and Wagner C. Stimulation of renin secretion by nitric oxide is mediated by phosphodiesterase 3. Proc Natl Acad Sci USA 95: 4743-4747, 1998.
22. Ng SSW and Pang CCY. Zaprinast, a type V phosphodiesterase inhibitor, dilates capacitance vessels in anaesthetized rats. Eur J Pharmacol 351: 323-328, 1998.
23. Noble AR, Abu-Kishk RA, D'Aloia MAE, Williams BC, and Lush DJ. Cyclic GMP-linked pathway for renin secretion. Kidney Int 46: 1588-1590, 1994.
24. Persson PB, Baumann JE, Ehmke H, Hackenthal E, Kirchhmein HR, and Nafz B. Endothelium-derived NO stimulates pressure-dependent renin release in conscious dogs. Am J Physiol Renal Fluid Electrolyte Physiol 264: F943-F947, 1993.
25. Reid IA. Role of nitric oxide in the regulation of renin and vasopressin secretion. Front Neuroendocrinol 15: 351-383, 1994.
26. Reid IA and Chou L. Effects of blockade of nitric oxide synthesis on the renin secretory response to furosemide in conscious rabbits. Clin Sci (Colch) 88: 657-663, 1995.
27. Sayago CM and Beierwaltes WH. Nitric oxide synthase and cGMP-mediated stimulation of renin secretion. Am J Physiol Regul Integr Comp Physiol 281: R1146-R1151, 2001.
28. Schricker K and Kurtz A. Liberators of NO exert a dual effect on renin secretion from isolated mouse renal juxtaglomerular cells. Am J Physiol Renal Fluid Electrolyte Physiol 265: F180-F186, 1993.
29. Singh I, Grams M, Wang WH, Yang T, Killen P, Smart A, Schnermann J, and Briggs JP. Coordinate regulation of renal expression of nitric oxide synthase, renin, and angiotensinogen mRNA by dietary salt. Am J Physiol Renal Fluid Electrolyte Physiol 270: F1027-F1037, 1996.
30. Vidal MJ, Romero JC, and Vanhoutte PM. Endothelium-derived relaxing factor inhibits renin release. Eur J Pharmacol 149: 401-402, 1988.
31. Wagner C, Pfeifer A, Ruth P, Hofmann F, and Kurtz A. Role of cGMP-kinase II in the control of renin secretion and renin expression. J Clin Invest 102: 1576-1582, 1998.